Nosocomial bloodstream infections caused by gram-negative bacilli: Epidemiology and risk factors for mortality;Epidemiología y factores de riesgo de mortalidad de las bacteriemias intrahospitalarias por bacilos gramnegativos

Revista Chilena de Infectologia

Volumn 25, Issue 5, 2008, Pages 368-373

  Lizaso, Diego ^a   Aguilera C , Karina ^a   Correa, Malena ^a   Yantorno, María Laura ^a   Cuitiño, Mario ^a   Pérez, Lorena ^a   Lares, Mónica ^a   De La Parra, Gloria ^a   Esposto, Amadeo ^a  

^a NONE

Author keywords

Bacteremia; Epidemiology; Gramnegative bacilli; Nosocomial infections; Outcome; Prognostic factors

Indexed keywords

ADOLESCENT; ADULT; AGED; ARGENTINA; ARTICLE; BACTEREMIA; CLASSIFICATION; CROSS INFECTION; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE INFECTION; HUMAN; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; MIDDLE AGED; MORTALITY; PROSPECTIVE STUDY; RISK FACTOR; STATISTICAL MODEL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ARGENTINA; BACTEREMIA; CROSS INFECTION; FEMALE; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 53849133484     PISSN: 07161018     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Wisplinghoff H, Bischoff T, Tallent S M, Seifert H, Wenzel R P, Edmond M B. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004; 39: 309-17.
2. Orsi G B, Di Stefano L, Noah N. Hospital-acquired, laboratory-confirmed bloodstream infection: increased hospital stay and direct costs. Infect Control Hosp Epidemiol 2002; 23: 190-7.
3. Garrouste-Orgeas M, Chevret S, Mainardi J L, Timsit J F, Misset B, Carlet J. A one-year prospective study of nosocomial bacteraemia in ICU and non-ICU patients and its impact on patient outcome. J Hosp Infect 2000; 44: 206-13.
4. Sligl W, Taylor G, Brindley P G. Five years of nosocomial Gram-negative bacteremia in a general intensive care unit: epidemiology, antimicrobial susceptibility patterns, and outcomes. Int J Infect Dis 2006; 10: 320-5.
5. Gaynes R, Edwards J R. Overview of nosocomial infections caused by gramnegative bacilli. Clin Infect Dis 2005; 41: 848-54.
6. Anderson D J, Engemann J J, Harrell L J, Carmeli Y, Reller L B, Kaye K S. Predictors of mortality in patients with bloodstream infection due to ceftazidime-resistant Klebsiella pneumoniae. Antimicrob Agents Chemother 2006; 50: 1715-20.
7. Kang C I, Kim S H, Park W B, Lee K D, Kim H B, Kim E C, et al. Bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy. Antimicrob Agents Chemother 2004; 48: 4574-81.
8. Arvanitidou M, Katikaridou E, Douboyas J, Tsakris A. Prognostic factors for nosocomial bacteraemia outcome: a prospective study in a Greek teaching hospital. J Hosp Infect 2005; 61: 219-24.
9. Wenzel R P, Edmond M B. The impact of hospital-acquired bloodstream infections. Emerg Infect Dis 2001; 7: 174-7.
10. Kang C I, Kim S H, Park W B, Lee K D, Kim H B, Kim E C, et al. Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome. Antimicrob Agents Chemother 2005; 49: 760-6.
11. Pop-Vicas A E, D'Agata E M. The rising influx of multidrug-resistant gram-negative bacilli into a tertiary care hospital. Clin Infect Dis 2005; 40: 1792-8.
12. Lee N Y, Lee H C, Ko N Y, Chang C M, Shih H I, Wu C J, et al. Clinical and economic impact of multidrug resistance in nosocomial Acinetobacter baumannii bacteremia. Infect Control Hosp Epidemiol 2007; 28: 713-9.
13. Falagas M E, Kasiakou S K, Rafailidis P I, Zouglakis G, Morfou P. Comparison of mortality of patients with Acinetobacter baumannii bacteraemia receiving appropriate and inappropriate empirical therapy. J Antimicrob Chemother 2006; 57: 1251-4.
14. Sunenshine RH, Wright MO, Maragakis LL, Harris AD, Song X, Hebden J, et al. Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalization. Emerg Infect Dis 2007; 13: 97-103.
15. Jerassy Z, Yinnon A M, Mazouz-Cohen S, Benenson S, Schlesinger Y, Rudensky B, et al. Prospective hospital-wide studies of 505 patients with nosocomial bacteraemia in 1997 and 2002. J Hosp Infect 2006; 62: 230-6.
16. Peralta G, Sánchez M B, Garrido J C, De Benito I, Cano M E, Martínez-Martínez L, et al. Impact of antibiotic resistance and of adequate empirical antibiotic treatment in the prognosis of patients with Escherichia coli bacteraemia. J Antimicrob Chemother 2007; 60: 855-63 Epub 2007: Jul 20.
17. Bantar C, Famiglietti A, Goldberg M. Three-year surveillance study of nosocomial bacterial resistance in Argentina. The Antimicrobial Committee; and the National Surveillance Program (SIR) Participants Group. Int J Infect Dis 2000; 4: 85-90.
18. Anatoliotaki M, Valatas V, Mantadakis E, Apostolakou H, Mavroudis D, Georgoulias V, et al. Bloodstream infections in patients with solid tumors: associated factors, microbial spectrum and outcome. Infection 2004; 32: 65-71.
19. Zaragoza R, Artero A, Camarena J J, Sancho S, González R, Nogueira J M. The influence of inadequate empirical antimicrobial treatment on patients with bloodstream infections in an intensive care unit. Clin Microbiol Infect 2003; 9: 412-8.
20. McGregor J C, Rich S E, Harris A D, Perencevich E N, Osih R, Lodise T P, Jr., et al. A systematic review of the methods used to assess the association between appropriate antibiotic therapy and mortality in bacteremic patients. Clin Infect Dis 2007; 45: 329-37.
21. Ibrahim E H, Sherman G, Ward S, Fraser V J, Kollef M H. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 2000; 118: 146-55.